GB0315691D0 - Boropeptides - Google Patents

Boropeptides

Info

Publication number
GB0315691D0
GB0315691D0 GB0315691A GB0315691A GB0315691D0 GB 0315691 D0 GB0315691 D0 GB 0315691D0 GB 0315691 A GB0315691 A GB 0315691A GB 0315691 A GB0315691 A GB 0315691A GB 0315691 D0 GB0315691 D0 GB 0315691D0
Authority
GB
United Kingdom
Prior art keywords
boropeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0315691A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trigen Ltd
Original Assignee
Trigen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trigen Ltd filed Critical Trigen Ltd
Priority to GB0315691A priority Critical patent/GB0315691D0/en
Publication of GB0315691D0 publication Critical patent/GB0315691D0/en
Priority to PT03255629T priority patent/PT1396270E/en
Priority to AU2003263333A priority patent/AU2003263333A1/en
Priority to CA002535788A priority patent/CA2535788A1/en
Priority to ES03255629T priority patent/ES2263924T3/en
Priority to EP04076548A priority patent/EP1561466A3/en
Priority to MXPA05002661A priority patent/MXPA05002661A/en
Priority to DE60304956T priority patent/DE60304956T2/en
Priority to DE60317039T priority patent/DE60317039T2/en
Priority to PL03376439A priority patent/PL376439A1/en
Priority to PCT/GB2003/003897 priority patent/WO2004022072A1/en
Priority to SI200330344T priority patent/SI1396270T1/en
Priority to SI200330345T priority patent/SI1400245T1/en
Priority to CA002536010A priority patent/CA2536010A1/en
Priority to PL376535A priority patent/PL376535A1/en
Priority to AU2003263328A priority patent/AU2003263328A1/en
Priority to KR1020057004077A priority patent/KR20050057295A/en
Priority to ES03255590T priority patent/ES2264515T3/en
Priority to JP2004569795A priority patent/JP2006511593A/en
Priority to EP04076521A priority patent/EP1466917A1/en
Priority to CA002535792A priority patent/CA2535792A1/en
Priority to PCT/GB2003/003887 priority patent/WO2004022071A1/en
Priority to MXPA05002662A priority patent/MXPA05002662A/en
Priority to EP06113648A priority patent/EP1695712A3/en
Priority to NZ539334A priority patent/NZ539334A/en
Priority to DE60305113T priority patent/DE60305113T2/en
Priority to AT04076510T priority patent/ATE376551T1/en
Priority to AU2003263343A priority patent/AU2003263343A1/en
Priority to CNB038213907A priority patent/CN100447151C/en
Priority to DK03255590T priority patent/DK1400245T3/en
Priority to NZ539333A priority patent/NZ539333A/en
Priority to JP2004569793A priority patent/JP2006509034A/en
Priority to DK03255629T priority patent/DK1396270T3/en
Priority to PCT/GB2003/003883 priority patent/WO2004022070A1/en
Priority to AT03255629T priority patent/ATE325611T1/en
Priority to EP03255629A priority patent/EP1396270B1/en
Priority to EP06113409A priority patent/EP1695711A3/en
Priority to US10/659,179 priority patent/US7112572B2/en
Priority to AT03255590T priority patent/ATE324899T1/en
Priority to CNB038214032A priority patent/CN100553639C/en
Priority to KR1020057004076A priority patent/KR20050057294A/en
Priority to JP2004569794A priority patent/JP2006503903A/en
Priority to EP04076510A priority patent/EP1466916B1/en
Priority to US10/658,971 priority patent/US7371729B2/en
Priority to BR0314450-0A priority patent/BR0314450A/en
Priority to EP03255590A priority patent/EP1400245B1/en
Priority to EP03255604A priority patent/EP1396269A1/en
Priority to US10/659,178 priority patent/US20050288253A1/en
Priority to HK04105939A priority patent/HK1063154A1/en
Priority to US10/937,854 priority patent/US20050176651A1/en
Priority to IL167294A priority patent/IL167294A/en
Priority to US11/077,620 priority patent/US20060084592A1/en
Priority to US11/078,097 priority patent/US20050282757A1/en
Priority to US11/438,823 priority patent/US20060229257A1/en
Priority to CY20061100903T priority patent/CY1105381T1/en
Priority to US11/980,398 priority patent/US20080234228A1/en
Priority to US12/109,129 priority patent/US20080287370A1/en
Priority to US12/380,572 priority patent/US20100035827A1/en
Priority to US12/384,780 priority patent/US20100036159A1/en
Priority to US12/481,134 priority patent/US20100113393A1/en
Ceased legal-status Critical Current

Links

GB0315691A 2002-09-09 2003-07-04 Boropeptides Ceased GB0315691D0 (en)

Priority Applications (60)

Application Number Priority Date Filing Date Title
GB0315691A GB0315691D0 (en) 2003-07-04 2003-07-04 Boropeptides
PT03255629T PT1396270E (en) 2002-09-09 2003-09-09 PROCESS FOR THE PREPARATION OF UTEISNCOMO INTERMEDIATE COMPOUNDS.
AU2003263333A AU2003263333A1 (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids for treating thrombosis
CA002535788A CA2535788A1 (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids for treating thrombosis
ES03255629T ES2263924T3 (en) 2002-09-09 2003-09-09 BORONIC ACID SALTS AND ITS USE IN THE PREPARATION OF MEDICINES FOR THE TROMBOSIS TREATMENT.
EP04076548A EP1561466A3 (en) 2002-09-09 2003-09-09 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
MXPA05002661A MXPA05002661A (en) 2002-09-09 2003-09-09 Boronic acid salts ant their use in the treatment of thrombosis.
DE60304956T DE60304956T2 (en) 2002-09-09 2003-09-09 Boric acid salts useful in parenteral formulations for selective thrombin inhibition
DE60317039T DE60317039T2 (en) 2002-09-09 2003-09-09 Peptidic boric acids and their use in the preparation of salts thereof
PL03376439A PL376439A1 (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids for treating thrombosis
PCT/GB2003/003897 WO2004022072A1 (en) 2002-09-09 2003-09-09 Boronic acid salts ant their use in the treatment of thrombosis
SI200330344T SI1396270T1 (en) 2002-09-09 2003-09-09 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
SI200330345T SI1400245T1 (en) 2002-09-09 2003-09-09 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition
CA002536010A CA2536010A1 (en) 2002-09-09 2003-09-09 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition
PL376535A PL376535A1 (en) 2002-09-09 2003-09-09 Boronic acid salts ant their use in the treatment of thrombosis
AU2003263328A AU2003263328A1 (en) 2002-09-09 2003-09-09 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition
KR1020057004077A KR20050057295A (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids for treating thrombosis
ES03255590T ES2264515T3 (en) 2002-09-09 2003-09-09 BORONIC ACID SALTS USED IN PARENTERAL FORMULATIONS FOR THE SELECTIVE INHIBITION OF THE THROMBIN.
JP2004569795A JP2006511593A (en) 2002-09-09 2003-09-09 Boronate and its use in the treatment of thrombosis
EP04076521A EP1466917A1 (en) 2002-09-09 2003-09-09 Method for making peptide boronic acids and acids obtainable thereby
CA002535792A CA2535792A1 (en) 2002-09-09 2003-09-09 Boronic acid salts ant their use in the treatment of thrombosis
PCT/GB2003/003887 WO2004022071A1 (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids for treating thrombosis
MXPA05002662A MXPA05002662A (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids for treating thrombosis.
EP06113648A EP1695712A3 (en) 2002-09-09 2003-09-09 Oral formulations for the selective inhibition of thrombin comprising boronic acid species
NZ539334A NZ539334A (en) 2002-09-09 2003-09-09 Multivalent metal salts of organoboronic acids for treating thrombosis
DE60305113T DE60305113T2 (en) 2002-09-09 2003-09-09 Boric acid salts and their use in the provision of drugs for thrombosis treatment
AT04076510T ATE376551T1 (en) 2002-09-09 2003-09-09 PEPTIDEBORIC ACIDS AND THEIR USE IN THE PRODUCTION OF SALTS THEREOF
AU2003263343A AU2003263343A1 (en) 2002-09-09 2003-09-09 Boronic acid salts ant their use in the treatment of thromobis
CNB038213907A CN100447151C (en) 2002-09-09 2003-09-09 Peptide boronic acids useful in making salts thereof
DK03255590T DK1400245T3 (en) 2002-09-09 2003-09-09 Boric acid salts useful for parenteral formulations for selective thrombin inhibition
NZ539333A NZ539333A (en) 2002-09-09 2003-09-09 Boronic acid salts and their use in the treatment of thrombosis
JP2004569793A JP2006509034A (en) 2002-09-09 2003-09-09 Boronates useful in parenteral formulations for selective thrombin inhibition
DK03255629T DK1396270T3 (en) 2002-09-09 2003-09-09 boronic acid salts
PCT/GB2003/003883 WO2004022070A1 (en) 2002-09-09 2003-09-09 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition
AT03255629T ATE325611T1 (en) 2002-09-09 2003-09-09 BORIC ACID SALTS AND THEIR USE IN THE PROVISION OF MEDICATIONS FOR THROMBOSIS TREATMENT
EP03255629A EP1396270B1 (en) 2002-09-09 2003-09-09 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
EP06113409A EP1695711A3 (en) 2002-09-09 2003-09-09 Parenteral formulations comprising boronic acid species for selective thrombin inhibition
US10/659,179 US7112572B2 (en) 2002-09-09 2003-09-09 Multivalent metal salts of boronic acids
AT03255590T ATE324899T1 (en) 2002-09-09 2003-09-09 BORIC ACID SALTS USABLE IN PARENTERAL FORMULATIONS FOR SELECTIVE THROMBIN INHIBITION
CNB038214032A CN100553639C (en) 2002-09-09 2003-09-09 Be used for the treatment of thrombotic boronic acid polyvalent salts
KR1020057004076A KR20050057294A (en) 2002-09-09 2003-09-09 Boronic acid salts and their use in the treatment of thrombosis
JP2004569794A JP2006503903A (en) 2002-09-09 2003-09-09 Boronic acid polyvalent metal salt for the treatment of thrombosis
EP04076510A EP1466916B1 (en) 2002-09-09 2003-09-09 Peptide boronic acids useful in making salts thereof
US10/658,971 US7371729B2 (en) 2002-09-09 2003-09-09 Boronic acid salts useful in parenteral formulations
BR0314450-0A BR0314450A (en) 2002-09-09 2003-09-09 Salts of boronic acid with the addition of a pharmaceutically acceptable base, pharmaceutical formulation, and use of said salts to prepare a pharmaceutical formulation.
EP03255590A EP1400245B1 (en) 2002-09-09 2003-09-09 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition
EP03255604A EP1396269A1 (en) 2002-09-09 2003-09-09 Boronic acid salts of multivalent metals used in the preparation of a medicament for treating thrombosis
US10/659,178 US20050288253A1 (en) 2002-09-09 2003-09-09 Boronic acid salts
HK04105939A HK1063154A1 (en) 2002-09-09 2004-08-09 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
US10/937,854 US20050176651A1 (en) 2002-09-09 2004-09-08 Peptide boronic acids useful in making salts thereof
IL167294A IL167294A (en) 2002-09-09 2005-03-07 Boronic acid salts and pharmaceutical compositions containing them for use in the treatment of thrombosis
US11/077,620 US20060084592A1 (en) 2002-09-09 2005-03-09 Peptide boronic acid inhibitors
US11/078,097 US20050282757A1 (en) 2002-09-09 2005-03-09 Peptide boronic acid compounds useful in anticoagulation
US11/438,823 US20060229257A1 (en) 2002-09-09 2006-05-22 Multivalent metal salts of boronic acids
CY20061100903T CY1105381T1 (en) 2002-09-09 2006-07-03 BORONIC ACID SALTS
US11/980,398 US20080234228A1 (en) 2002-09-09 2007-10-31 Boronic acid salts
US12/109,129 US20080287370A1 (en) 2002-09-09 2008-04-24 Boronic Acid Salts Useful in Parenteral Formulations
US12/380,572 US20100035827A1 (en) 2002-09-09 2009-02-26 Multivalent metal salts of boronic acids
US12/384,780 US20100036159A1 (en) 2002-09-09 2009-04-07 Peptide boronic acid inhibitors
US12/481,134 US20100113393A1 (en) 2002-09-09 2009-06-09 Boronic Acid Salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0315691A GB0315691D0 (en) 2003-07-04 2003-07-04 Boropeptides

Publications (1)

Publication Number Publication Date
GB0315691D0 true GB0315691D0 (en) 2003-08-13

Family

ID=27741587

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0315691A Ceased GB0315691D0 (en) 2002-09-09 2003-07-04 Boropeptides

Country Status (1)

Country Link
GB (1) GB0315691D0 (en)

Similar Documents

Publication Publication Date Title
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
DE502004003476D1 (en) Standfuss
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DE502004011343D1 (en) Rotorspinnmaschine
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004012153D1 (en) Rotorspinnmaschine
DE10394343D2 (en) Berührungslose biometrische erkennung
GB2384718B (en) Carry curbz
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
DE602004008281D1 (en) Avermectin-b1-monosaccharidderivative
GB0321285D0 (en) M-sword
GB0315691D0 (en) Boropeptides
GB0323831D0 (en) Walbum
GB0220828D0 (en) Boropeptides
GB0220822D0 (en) Boropeptides
GB0220829D0 (en) Boropeptides
GB0220764D0 (en) Boropeptides
GB0220823D0 (en) Boropeptides
GB0220830D0 (en) Boropeptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)